Kalaris Therapeutics Inc (KLRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 115,698 | 106,092 | 123,834 | 71,093 | 100,206 |
| Marketable Securities | 86,872 | 127,703 | 140,273 | 101,580 | 101,169 |
| Receivables | 244 | 157 | N/A | N/A | N/A |
| Other current assets | 0 | 0 | 261 | 91 | 172 |
| TOTAL | $212,275 | $243,052 | $272,042 | $176,517 | $206,441 |
| Non-Current Assets | |||||
| PPE Net | 844 | 930 | 943 | 997 | 1,083 |
| Other Non-Current Assets | 30,925 | 33,097 | 20,713 | 22,481 | 23,566 |
| TOTAL | $31,769 | $34,027 | $21,656 | $23,478 | $24,649 |
| Total Assets | $244,044 | $277,079 | $293,698 | $199,995 | $231,090 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,134 | 3,004 | 4,889 | 5,518 | 4,473 |
| Accrued Expenses | 12,289 | 13,985 | 13,677 | 13,115 | 10,083 |
| Other current liabilities | 136 | 56 | 81 | 563 | 1,220 |
| TOTAL | $24,959 | $24,338 | $20,719 | $21,588 | $18,639 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 25,553 | 28,222 | 19,753 | 20,270 | 20,776 |
| TOTAL | $25,553 | $28,222 | $19,753 | $20,270 | $20,776 |
| Total Liabilities | $50,512 | $52,560 | $40,472 | $41,858 | $39,415 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,071 | 4,066 | 4,053 | 4,048 | 2,846 |
| Common Shares | 9 | 9 | 9 | 7 | 7 |
| Retained earnings | -506,958 | -465,775 | -427,639 | -385,567 | -340,928 |
| Other shareholders' equity | -301 | -468 | -563 | -444 | -350 |
| TOTAL | $193,532 | $224,519 | $253,226 | $158,137 | $191,675 |
| Total Liabilities And Equity | $244,044 | $277,079 | $293,698 | $199,995 | $231,090 |